3M Drug Delivery Systems Grows Partnerships in Asia

April 15, 2010

ST. PAUL, Minn., April 15 /PRNewswire-Asia/ — 3M Drug Delivery Systems
recently advanced its participation in the Asian market with a sponsorship of
the Asia Pharma R&D Leaders 2010 event, held March 4 and 5 in Shanghai, China.
The event, organized by Global Leaders Institute, the leading life science
event producer in China, brings together leading pharmaceutical industry
professionals, policymakers, and academics to discuss Asia’s role in the
manufacturing, research and development of today’s drug and biotech
innovations, as well as opportunities for future growth.

3M Drug Delivery Systems is playing an active role in the growth of the
pharmaceutical industry in Asia, with its recent construction of a new
laboratory facility at the 3M Singapore site in Yishun. The laboratory is 3M
Drug Delivery Systems’ first contract research and development facility in the
Asia Pacific region dedicated to pharmaceutical product development. The
country’s infrastructure makes it an ideal hub for 3M’s Asia Pacific customers
and Singapore’s scientific talent pool adds to the site’s appeal. The
Singapore lab will develop products in both the inhalation and transdermal
drug delivery categories, bringing 3M’s innovative inhalers and patches to
pharmaceutical customers and patients in the Asia Pacific region.

Research conducted at the Singapore facility will contribute to 3M Drug
Delivery Systems’ growing capabilities and product portfolio. Since its
invention of the metered-dose inhaler (MDI) 50 years ago, the company has
remained a pioneer in the technology and now offers a full suite of MDI
development and manufacturing capabilities and components, including the 3M(TM)
Integrated Dose by Dose Counter. Additional technologies are available to
improve patient experiences and help ensure the technical success of clients’

Other recent offerings in inhalation include the 3M(TM) Taper Dry Powder
Inhaler, which stores API on a microstructured carrier tape, virtually
eliminating the need for lactose or complex powder formulations as well as 3M
Conix(TM) Dry Powder Inhaler, which uses reverse-flow cyclone technology to
enable a patient’s inhalation to efficiently aerosolize the drug. The company
has also recently introduced two new inhaler components, the 3M(TM) Face Seal
Valve, which eliminates the need to prime an inhaler, and 3M(TM) Plasma
Coating Technology, which provides protection from degradation, deposition and

In addition to its inhalation and transdermal technologies, the company
also offers a portfolio of TLR-based vaccine adjuvants, as well as services in
Transdermal components, packaging films and manufacturing. In addition to its
Singapore laboratory, the company has research facilities in the US and the UK,
as well as manufacturing sites in the US, UK, and South America.

For more information, visit http://www.3M.com/dds .

About 3M Drug Delivery Systems

3M Drug Delivery Systems partners with pharmaceutical and biotech
companies to develop pharmaceuticals using 3M’s inhalation or transdermal drug
delivery technology. 3M offers a full range of feasibility, development and
manufacturing capabilities combined with regulatory guidance to help bring
products to market. In-house resources, including toxicology, regulatory
expertise, quality assurance, operations, and marketed product support, are
available for each step of the development and commercialization process. This
depth of resources is one reason why more than 50 percent of all metered-dose
inhalers worldwide and 80 percent of all transdermal systems in the United
utilize 3M drug delivery technology. For more information, please
visit http://www.3M.com/dds or call 1-800-643-8086.

About 3M Health Care

3M Health Care, one of 3M’s six major business segments, provides world-
class innovative products and services to help health care professionals
improve the practice, delivery and outcome of patient care in medical, oral
care, drug delivery and health information markets.

3M is a trademark of 3M Company.

About Global Leaders Institute

Global Leaders Institute is the producer and organizer of top-level
business events. We focus on the development and operation of the strategic,
market leading business conference. We focus on the specialty spirit and
professional attainment. We focus on value creation for our client. We
provide 60 annual conferences across energy, finance, transportation, life
science, real estate, telecom and media, etc. each year. For more information,
please visit http://www.globaleaders.com .

    For further information, please contact:

     Michael Gugala
     Karwoski & Courage
     Tel:   +1-612-342-9604
     Email: m.gugala@creativepr.com

SOURCE Global Leaders Institute

Source: newswire

comments powered by Disqus